5/5/15 Subcommittee on Antimicrobial Susceptibility Testing Disclosure Summary

Transcription

1 Subcommittee on Antimicrobial Susceptibility Testing Disclosure Summary Personal, Professional, and Financial Interests Relevant to the field(s) of work in which I would be involved with CLSI, I list below the organizations and activities with which I participate. For example, please list any controlling financial interest or benefit you may hold or have received including consulting fees or paid advisory boards, equity ownership/stock options or other information which your colleagues would need to know in order to fairly assess the basis of your position related to the CLSI activities (from past 3 years). Jean B. Patel, PhD, D(ABMM) Chairholder Centers for Disease Control and Prevention None Franklin R. Cockerill, III, MD Vice Chairholder Scientific Advisory Boards: Roche Diagnostics, Abbott Molecular, NanoMR. Royalties for Patents/Licenses: Roche Diagnostics, TIB MOBIOL. Government Special Employee: Chair, Microbiology Devices Panel, FDA; Member, Scientific Advisory Counsel, CDC. Scientific advisor to SVBio; Potential equity/stock ownership in pharmaceutical companies and device manufacturers: President, Cockerill Fertilizer, Inc. (a real estate, bond, stock/ equity holding enterprise). Richard B. Thomson, Jr., PhD- Chairholder, Consensus Committee on Microbiology Evanston Hospital, NorthShore University HealthSystem Received honoraria, consulting fees or research funding in the past three years from International Health Management Associates, GlaxoSmithKline, BD GeneOhm, and 6 not-forprofit universities and microbiology societies. John H. Rex, MD, FACP Vice Chairholder, Consensus Committee on Microbiology AstraZeneca Employee and shareholder of AstraZeneca Pharmaceuticals Non-Executive Director and shareholder of F2G Pharmaceuticals Consultant to Advent Life Sciences, an investor in F2G Pharmaceuticals Members: George M. Eliopoulos, MD Beth Israel Deaconess Medical Center Cubist Pharmaceuticals--Advisory board Durata-Consultation Rempex-Advisory boards Wockhardt Ltd.-Consultation Theravance Pharmaceuticals Stephen G. Jenkins, PhD, D(ABMM),F(AAM) New York Presbyterian Hospital Advisory boards for Pfizer, Achaogen, Actavis, Theravance,The Medicines Company, Bayer, and Merck. 1

2 James S. Lewis, II, PharmD, FIDSA Oregon Health & Science University Consultant Acceler8 technology, Astellas, Forest, Merck, Pfizer, Trius, Cubist, Rempex, and Theravance Speakers Bureau Astellas, Forest, Merck Brandi Limbago, PhD Centers for Disease Control and Prevention None David P. Nicolau PharmD, FCCP, FIDSA Hartford Hospital Consultant, grant recipient and/or on the speaker's bureau for the following entities: Actavis, AstraZeneca, Bayer, Cubist, GSK, Merck, Pfizer, Macrolide Pharmaceuticals, Melinta, Tetraphase, The Medicines Company. Robin M. Patel, MD Mayo Clinic Employee of Mayo Clinic Research funding: Pfizer, Pradama, Tornier, Astellas, Pocared, nanomr, BioFire, Nanosphere, Curetis, Check-Points, National Institutes of Health, 3M, Cubist/Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Actavis Instrument evaluation/reagents: biomérieux, Bruker, Abbott, Nanosphere, Siemens, BD Consultant: St. Jude, Thermo Fisher Scientific, Curetis Associate Editor s Stipend: Journal of Clinical Microbiology Vice Chair/Chair, ICAAC Program Planning Committee Patents: B. pertussis PCR, anti-biofilm substance, device/method for sonication Mair Powell, MD, FRCP, FRCPath MHRA None Sandra S. Richter, MD, D(ABMM) Cleveland Clinic Research grants BD Diagnostics, OpGen, biomerieux, Nanosphere, Cerexa, Pocared, Biofire Diagnostics, Achaogen Pharmaceuticals Speaker honorarium biomerieux Editor stipen Journal of Clinical Microbiology, Manual of Clinical Microbiology John D. Turnidge, MD Women's and Children's Hospital None Advisory boards for Novartis Australia, Pfizer Australia and AstraZeneca Australia Visiting speaker for biomeriuex 2

3 Melvin P. Weinstein, MD Rutgers Robert Wood Johnson Medical School Research support in from Beckman Coulter (Siemens), BD Diagnostics, JMI Laboratories, Taxis Pharmaceuticals. Consulted for PDL Biopharma, Accelerate Diagnostics, and Rempex Pharmaceuticals. Barbara L. Zimmer, PhD Beckman Coulter, Inc. Employee of Beckman Coulter, Inc. which purchased the Microbiology Business Unit (MicroScan) from Siemens Healthcare Diagnostics 2/1/15 Advisors: Jeff Alder, PhD Bayer Healthcare Employee and stockholder for Bayer HealthCare Other: NIH/NIAID grant and contract reviewer. Patricia A. Bradford, PhD AstraZeneca Employee of AstraZeneca Pharmaceuticals William B. Brasso, BS BD Diagnostic Systems Employee of BD Diagnostic Systems Dr. Rafael Canton ESCMID and EUCAST Ad-hoc member of the ESCMID (the European Society of Clinical Microbiology and Infectious Diseases) Executive Committee. Chairman of EUCAST (European Committee of Antimicrobial Susceptibility Testing). Michael N. Dudley, PharmD, FIDSA Rempex Pharmaceuticals (a wholly owned subsidiary of the Medicines Company) Employee of Rempex Pharmaceuticals, Inc. Graeme Forrest, MBBS Portland VA Healthcare System None Marcelo Galas National Institute of Infections Diseases, Ministry of Health None Howard S. Gold, MD Beth Israel Deaconess Medical Center None 3

4 Dwight J. Hardy, PhD University of Rochester Medical Center Consultant Cempra Pharmaceuticals; Grants/Contracts Curetis, International Health Management Associates (IHMA), Jones Group, Clinical Microbiology Institute, Micromyx Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System APHL Speaker's honoraria: biomerieux, Inc. Consultant: Accelerate Diagnostics, Inc.; Association of Public Health Labs; Theravance BioPharma, Inc. Romney M Humphries, PhD D(ABMM) UCLA David Geffen School of Medicine Research grants - Cubist Pharmaceuticals, biomerieux, Quidel, Siemens, GenMark, Curetis, Luminex, BD, Beckman Coulter, Accelarate Diagnostics Speaker Honorarium Cubist Pharmaceuticals Advisory Board Nanosphere, Gene Weave Amy Mathers, MD University of Virginia Medical Center Research: Rempex Pharmaceuticals Consultant for Rempex Pharmaceuticals Tony Mazzulli, MD, FRCP(C), FACP Mount Sinai Hospital President: Canadian Association of HIV Clinical Laboratory Specialists Medical Microbiology Section Head, Association of Medical Microbiologists and Infectious Diseases (AMMI) Canada Speaker Honorarium: Abbott, Merck, Roche Advisory Board: Qvella Corporation, Pfizer, Roche Linda A. Miller, PhD GlaxoSmithKline Employee of GlaxoSmithKline Pharmaceuticals Melissa B. Miller, PhD, D(ABMM) University of North Carolina School of Medicine None Sumati Nambiar, MD, MPH FDA Center for Drug Evaluation and Research None 4

5 Cathy A. Petti, MD University of South Florida Consultant: NanoMR, Inc, Menon International, Inc, and Nanosphere, Inc. Uncompensated advisor to isentio. Helio S. Sader, MD, PhD JMI Laboratories JMI Laboratories, Inc. has also received research and educational grants in from Achaogen, Actelion, Affinium, American Proficiency Institute (API), AmpliPhi Bio, Anacor, Astellas, AstraZeneca, Basilea, BioVersys, Cardeas, Cempra, Cerexa, Cubist, Daiichi, Dipexium, Durata, Fedora, Forest, Furiex, Genentech, GlaxoSmithKline, Janssen, Johnson & Johnson, Medpace, Meiji Seika Pharma, Melinta, Merck, Methylgene, Nabriva, Nanosphere, Novartis, Pfizer, Polyphor, Rempex, Roche, Seachaid, Shionogi, Synthes, The Medicines Co., Theravance, ThermoFisher, Venatorx, Vertex and Waterloo. Some JMI employees are advisors/consultants for Astellas, Cubist, Pfizer, Cempra, Cerexa- Forest, and Theravance. In regards to speakers bureaus and stock options-none to declare. Michael J. Satlin, MD, MS Weill Cornell Medical College/ NewYork-Presbyterian Hospital Research contract: Achaogen (Site PI of a clinical trial of an investigational antimicrobial agent) Paul C. Schreckenberger, PhD, D(ABMM), F(AAM) Loyola University Medical Center Speaker Bureau: Merck & Company, Cubist Pharmaceuticals Research Grants: Accelerate Diagnostics, Becton Dickinson, Beckman Coulter, BioFire, biomerieux, Bruker, Center for Anti-Infective Research and Development (CAIRD), Cepheid, International Health Management Associates (IHMA), JMI Laboratories, Kimberly-Clark, Micromyx Honorarium: Accelerate Diagnostics, Beckman-Coulter, BioFire, Cepheid, Hardy Diagnostics, ThermoFisher Advisory Boards: Cempra Inc., Cepheid, GenMark, Quidel, ThermoFisher Audrey N. Schuetz, MD, MPH, D(ABMM) Weill Cornell Medical College/ NewYork-Presbyterian Hospital Received honoraria from 2 non-for-profit universities, a microbiology society, and a pathology society. Susan E. Sharp, Ph.D., DABMM, FAAM ASM None Ribhi M. Shawar, Ph.D, D(ABMM) FDA Ctr. For Devices/Rad. Health None Kerry Snow, MS, MT(ASCP) FDA Center for Drug Evaluation and Research None 5

6 Pranita Tamma, MD, MHS John Hopkins University School of Medicine Research grant funded jointly by Pfizer and The Joint Commission entitled What is the Optimal Antimicrobial Stewardship Strategy: Pre-Prescription Authorization or Post-Prescription Review and Feedback? Investigator-initiated grant funded by Merck entitled The effectiveness of piperacillin-tazobactam versus ertapenem for the treatment of intra-abdominal infections involving Enterococcus faecalis. Maria M. Traczewski, BS, MT(ASCP) The Clinical Microbiology Institute CMI has received research grants/contracts past and present from the following companies:astrazeneca, Cubist, GlaxoSmithKline, Pfizer, Pfizer Animal Health, Merck, Astellas, Theravance, Novartis, Paratek, Merck Animal Health, Elanco, Cardeas, BioMerieux, Gilead, Intervet, Vertex, Cornerstone Therapeudics, Cerexa, Shering-Plough Vet. Division, MAP Pharmaceuticals, APP Pharmaceuticals, Novexel, Protez, Leo, Oscient, Achaogen, Trius, Replidyne, Bausch and Lomb, Blanca, Johnson & Johnson, Wyeth, Sanofi- Aventis, Dechra Pharmaceuticals, APP Pharmaceuticals, Symbiomix Therapeutics, Cepheid Inc., Siemens Healthcare Diagnostics, Advanced Food Technologies, Becton-Dickinson, Stanford University, Dermira Inc. and Basilea Pharmaceutica. Hui Wang, PhD Peking University People s Hospital Grant recipient for resistance surveillance from Sanofi-Aventis Co., Pfizer and Sumitomo 6